FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988157903> ?p ?o ?g. }

• W1988157903 endingPage "2550" @default.
• W1988157903 startingPage "2544" @default.
• W1988157903 abstract "Polysulfated polysaccharides are attractive candidates for antiviral drug development because of their potent in vitro activities against human immunodeficiency virus (HIV), herpesviruses, and other enveloped viruses. To determine the potential anti-HIV activity of a prototypical polysulfated polysaccharide, we administered the maximally tolerated dose of dextran sulfate by continuous intravenous infusion to 10 subjects with symptomatic HIV infection for up to 14 days. Since parenteral dextran sulfate is an anticoagulant, the infusion was adjusted to produce the greatest acceptable increase in activated partial thromboplastin time. Drug concentrations in plasma achieved with this protocol were up to 200-fold greater than the 50% inhibitory concentration for free HIV infectivity in vitro. Despite this, circulating HIV antigen (p24) levels increased in all eight subjects who received the drug for more than 3 days (median proportional increase, 73.5%; range, 32 to 130%); this increase was highly significant when it was compared with that in a large cohort of untreated historical controls (Fisher's exact test, P less than 0.001). Frequent decreases in infusion rate were required in all subjects to maintain a constant activated partial thromboplastin time; plasma dextran sulfate levels did not fall as the infusion rate decreased, suggesting a decline in estimated drug clearance over time. Continuous intravenous dextran sulfate was toxic, producing profound but reversible thrombocytopenia in all eight subjects who received drug for more than 3 days and extensive but reversible alopecia in five of these subjects. Because of its toxicity and lack of beneficial effect on surrogate markers, dextran sulfate is unlikely to have a practical role in the treatment of symptomatic HIV infection." @default.
• W1988157903 created "2016-06-24" @default.
• W1988157903 creator A5009228936 @default.
• W1988157903 creator A5011564045 @default.
• W1988157903 creator A5017420608 @default.
• W1988157903 creator A5023489066 @default.
• W1988157903 creator A5046778665 @default.
• W1988157903 creator A5053567182 @default.
• W1988157903 creator A5061636913 @default.
• W1988157903 creator A5071106707 @default.
• W1988157903 creator A5077256450 @default.
• W1988157903 creator A5079821194 @default.
• W1988157903 date "1991-12-01" @default.
• W1988157903 modified "2023-10-14" @default.
• W1988157903 title "Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection" @default.
• W1988157903 cites W1547229107 @default.
• W1988157903 cites W1608651908 @default.
• W1988157903 cites W1819532157 @default.
• W1988157903 cites W1964037828 @default.
• W1988157903 cites W1969931362 @default.
• W1988157903 cites W1988608733 @default.
• W1988157903 cites W1992773224 @default.
• W1988157903 cites W2020933095 @default.
• W1988157903 cites W2038354376 @default.
• W1988157903 cites W2040168494 @default.
• W1988157903 cites W2043388188 @default.
• W1988157903 cites W2045169026 @default.
• W1988157903 cites W2057461438 @default.
• W1988157903 cites W2062555652 @default.
• W1988157903 cites W2069094887 @default.
• W1988157903 cites W2071551278 @default.
• W1988157903 cites W2088372034 @default.
• W1988157903 cites W2090206687 @default.
• W1988157903 cites W2094713371 @default.
• W1988157903 cites W2108385781 @default.
• W1988157903 cites W2112362416 @default.
• W1988157903 cites W2132936712 @default.
• W1988157903 cites W2318770038 @default.
• W1988157903 cites W2325115797 @default.
• W1988157903 cites W2332694807 @default.
• W1988157903 cites W2408162466 @default.
• W1988157903 cites W2418273866 @default.
• W1988157903 cites W2439838463 @default.
• W1988157903 cites W39413060 @default.
• W1988157903 cites W85615424 @default.
• W1988157903 doi "https://doi.org/10.1128/aac.35.12.2544" @default.
• W1988157903 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/245428" @default.
• W1988157903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1810188" @default.
• W1988157903 hasPublicationYear "1991" @default.
• W1988157903 type Work @default.
• W1988157903 sameAs 1988157903 @default.
• W1988157903 citedByCount "142" @default.
• W1988157903 countsByYear W19881579032012 @default.
• W1988157903 countsByYear W19881579032013 @default.
• W1988157903 countsByYear W19881579032014 @default.
• W1988157903 countsByYear W19881579032015 @default.
• W1988157903 countsByYear W19881579032016 @default.
• W1988157903 countsByYear W19881579032018 @default.
• W1988157903 countsByYear W19881579032019 @default.
• W1988157903 countsByYear W19881579032020 @default.
• W1988157903 countsByYear W19881579032021 @default.
• W1988157903 countsByYear W19881579032022 @default.
• W1988157903 countsByYear W19881579032023 @default.
• W1988157903 crossrefType "journal-article" @default.
• W1988157903 hasAuthorship W1988157903A5009228936 @default.
• W1988157903 hasAuthorship W1988157903A5011564045 @default.
• W1988157903 hasAuthorship W1988157903A5017420608 @default.
• W1988157903 hasAuthorship W1988157903A5023489066 @default.
• W1988157903 hasAuthorship W1988157903A5046778665 @default.
• W1988157903 hasAuthorship W1988157903A5053567182 @default.
• W1988157903 hasAuthorship W1988157903A5061636913 @default.
• W1988157903 hasAuthorship W1988157903A5071106707 @default.
• W1988157903 hasAuthorship W1988157903A5077256450 @default.
• W1988157903 hasAuthorship W1988157903A5079821194 @default.
• W1988157903 hasBestOaLocation W19881579032 @default.
• W1988157903 hasConcept C112705442 @default.
• W1988157903 hasConcept C126322002 @default.
• W1988157903 hasConcept C185592680 @default.
• W1988157903 hasConcept C203014093 @default.
• W1988157903 hasConcept C2777339698 @default.
• W1988157903 hasConcept C2778261982 @default.
• W1988157903 hasConcept C2780035454 @default.
• W1988157903 hasConcept C29730261 @default.
• W1988157903 hasConcept C55493867 @default.
• W1988157903 hasConcept C71924100 @default.
• W1988157903 hasConcept C89560881 @default.
• W1988157903 hasConcept C98274493 @default.
• W1988157903 hasConceptScore W1988157903C112705442 @default.
• W1988157903 hasConceptScore W1988157903C126322002 @default.
• W1988157903 hasConceptScore W1988157903C185592680 @default.
• W1988157903 hasConceptScore W1988157903C203014093 @default.
• W1988157903 hasConceptScore W1988157903C2777339698 @default.
• W1988157903 hasConceptScore W1988157903C2778261982 @default.
• W1988157903 hasConceptScore W1988157903C2780035454 @default.
• W1988157903 hasConceptScore W1988157903C29730261 @default.
• W1988157903 hasConceptScore W1988157903C55493867 @default.
• W1988157903 hasConceptScore W1988157903C71924100 @default.
• W1988157903 hasConceptScore W1988157903C89560881 @default.

• next